Skip to Content
Print Share

Inrebic Prices, Coupons and Patient Assistance Programs

Inrebic (fedratinib) is a member of the multikinase inhibitors drug class and is commonly used for Myelofibrosis.

Inrebic Prices

The cost for Inrebic oral capsule 100 mg is around $22,920 for a supply of 120 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Inrebic is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Inrebic availability.

This Inrebic price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Capsule

100 mg Inrebic oral capsule
from $22,920.08 for 120 capsule
Quantity Per unit Price
120 $191.00 $22,920.08

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Inrebic Coupons and Rebates

Inrebic offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Inrebic Celgene Co-Pay Program: Eligible commercially insured patients co-pay may be reduced to $25 per prescription with savings of up to $10,000 per enrollment period; for additional information contact the program at 800-931-8691 ext 4102.

Applies to:Inrebic
Number of uses:per prescription per calendar year

More information please phone: 800-931-8691
Visit Website

Patient Assistance Programs for Inrebic

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Celgene Patient Support

Elligibility requirements:
  1. Determined case by case
  2. At or below 650% of FPL
  3. Any diagnosis deemed medically necessary by the patient's oncologist
  4. The patient must also be a US resident with a prescription from a US doctor.
  5. This program also provides copay assistance.

Applicable drugs:

  • Inrebic (fedratinib) Capsule

More information please phone: 800-931-8691
Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Inrebic (fedratinib) Capsule

More information please phone: 866-316-7263
Visit Website

Provider: Good Days Program

Elligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Inrebic (fedratinib) Capsule

More information please phone: 877-968-7233
Visit Website

Provider: Bristol Myers Squibb (BMS) Patient Support Program (Expanded: COVID-19)

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US.
  5. Eligibility determined on a case-by-case basis. Contact program for details: 1-800-721-8909

Applicable drugs:

  • Inrebic (fedratinib) Capsule

More information please phone: 800-721-8909
Visit Website